Compare ARK Genomic Revolution ETF (ARKG) vs Innodata Inc (INOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Innodata Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.8, while Innodata Inc trades at $67.57 (market cap $2.21B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Innodata Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | INOD | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $121.50 |
52-Week Low | $23.09 | $34.45 |
Market Cap | — | $2.21B |
Enterprise Value | — | $2.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
INOD trades at $67.80, down 1.99% amid bearish technical signals despite strong fundamental performance. The stock shows robust revenue growth with 2025 revenue of $251.66M and net income of $32.18M, supported by consistent earnings beats. Analyst consensus remains bullish with a $130 price target, though recent insider selling and technical weakness create near-term pressure.
Outlook remains positive given AI-driven growth potential and strong profitability metrics, but investors face volatility risks from high valuation multiples and competitive pressures in the AI data services space. The stock's current pullback presents a potential entry point for long-term investors believing in the AI growth story.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →
